“ "One of the most significant transformations relates to the regulatory area, with Brazil undoubtedly moving closer to international standards over the past five years." ”
In Conversation
“ "Brazil is the sixth largest pharmaceutical market in the world and we are steadily moving toward the fifth position, which we will probably reach within the… ”
“ "In 2016, Brazil’s overall inflation rate reached 19.8 percent, but the quality of services accessible to our patients is far from increasing at the same pace… ”
“ PharmaBoardroom spoke to Fabrice Chouraqui, President of Novartis Latin America and Canada at the Financial Times LatAm Healthcare & Life Sciences Summit in September 2015. He… ”
There is little publicly available information on your personal history and the founding of Meizler. Can you share that story for our readers? Everybody has a…
Diabetes affects an estimated 6 million Brazilians, a figure which is expected to double by 2025, in line with many other developing nations. Like many other…
When we interviewed you four years ago, you gave us a picture of the industry. How has that picture changed since then? We can start with…
Hypermarcas is a huge, diversified corporation that sells everything from shampoo, to medicine. Would you consider it more of a consumer goods company that happens to…
Many readers may find it counterintuitive that SINDUSFARMA, which represents syndicates, is organized by a team of management executives. Historically, these two groups tend to be…
What would you recommend in terms of increasing the competitiveness and growth of the Brazilian pharmaceutical industry? The Brazilian pharmaceutical industry needs to improve its R&D…
We know the raw data already in the Brazilian market and the number changes since our last visit in 2007 – but how would you interpret…
Minister Pimentel recently released the BrasilMaior plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend the government innovate, compete, and grow…
